ABCL实时信号 | 通过Getagraph.com最大化利润

出售 115314 min ago

@ $5.26

发出时间: 15 Feb 2024 @ 03:38

回报率: -23.31%

上一信号: Feb 15 - 01:00

上一信号: 购买

回报率: 1.06 %

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

Stats
今日成交量	2.20M
平均成交量	1.37M
市值	1.18B
EPS	$0 ( 2024-05-02 )
下一个收益日期	( $-0.160 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.90
ATR14	$0.0110 (0.27%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-26	Hansen Carl L. G.	Sell	56 125	Share option (right to buy)
2024-02-26	Hansen Carl L. G.	Buy	56 125	Common Shares
2024-01-14	Lecault Veronique	Buy	770 416	Share option (right to buy)
2024-01-14	Stimart Tryn	Buy	616 333	Share option (right to buy)
2024-01-14	Booth Andrew	Buy	770 416	Share option (right to buy)

INSIDER POWER
79.71
Last 95 transactions
Buy: 16 009 839 \| Sell: 26 316 378

音量相关性

長: -0.25 (neutral)

短: 0.96 (very strong)

Signal:(50.7) Expect same movement, but be aware

AbCellera Biologics Inc. 相关性

10 最正相关
SVAC	0.967
STOK	0.963
CROX	0.96
GSIT	0.957
CTXR	0.957
VIR	0.955
JBLU	0.954
TPIC	0.953
FGEN	0.952
OPRA	0.95

10 最负相关
RMBS	-0.984
NETE	-0.973
AMRB	-0.972
MMAC	-0.956
BRIVU	-0.952
MSDA	-0.95
SCR	-0.95
IMOS	-0.949
KE	-0.948
EBSB	-0.947

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

AbCellera Biologics Inc. 相关性 - 货币/商品

0.48
( neutral )

0.86
( strong )

0.00
( neutral )

-0.20
( neutral )

0.61
( weak )

AbCellera Biologics Inc. 财务报表

Annual	2023
营收:	$38.03M
毛利润:	$7.13M (18.75 %)
EPS:	$-0.510

FY	2023
营收:	$38.03M
毛利润:	$7.13M (18.75 %)
EPS:	$-0.510

FY	2022
营收:	$485.42M
毛利润:	$418.99M (86.31 %)
EPS:	$0.560

FY	2021
营收:	$375.20M
毛利润:	$329.69M (87.87 %)
EPS:	$0.960

Financial Reports:

No articles found.

AbCellera Biologics Inc.

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

实时更新： AbCellera Biologics Inc. [ABCL]

Upcoming Earnings Alert